Peer Review reports
From: Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
| Original Submission | ||
|---|---|---|
| 20 Sep 2009 | Submitted | Original manuscript |
| 20 Sep 2009 | Author responded | Author comments - Da-zhi Xu |
| Resubmission - Version 2 | ||
| 20 Sep 2009 | Submitted | Manuscript version 2 |
| 20 Sep 2009 | Author responded | Author comments - Da-zhi Xu |
| 14 Nov 2009 | Reviewed | Reviewer Report - Volker Wacheck |
| 23 Nov 2009 | Reviewed | Reviewer Report - Leri Faried |
| 11 May 2010 | Reviewed | Reviewer Report - Brian Egleston |
| Resubmission - Version 3 | ||
| 20 Sep 2009 | Submitted | Manuscript version 3 |
| 29 May 2010 | Author responded | Author comments - Da-zhi Xu |
| Resubmission - Version 4 | ||
| 29 May 2010 | Submitted | Manuscript version 4 |
| 22 Jun 2010 | Reviewed | Reviewer Report - Brian Egleston |
| 30 Jun 2010 | Reviewed | Reviewer Report - Leri Faried |
| 13 Jul 2010 | Reviewed | Reviewer Report - Volker Wacheck |
| 23 Aug 2010 | Author responded | Author comments - Da-zhi Xu |
| Resubmission - Version 5 | ||
| 23 Aug 2010 | Submitted | Manuscript version 5 |
| 6 Sep 2010 | Reviewed | Reviewer Report - Volker Wacheck |
| 2 Oct 2010 | Author responded | Author comments - Da-zhi Xu |
| Resubmission - Version 6 | ||
| 2 Oct 2010 | Submitted | Manuscript version 6 |
| Publishing | ||
| 7 Oct 2010 | Editorially accepted | |
| 7 Oct 2010 | Article published | 10.1186/1471-2407-10-536 |
You can find further information about peer review here.